The Food and Drug Administration says it confirmed three new cases of a potentially (it’s so easy to say “potential” when “only” 98% of the patients die) lethal brain inflammation linked to the multiple sclerosis drug Tysabri.

There have been 13 reported cases of progressive multifocal leukoencephalopathy, or PML, since mid-2006. The reports are the first confirmed new cases since June. While the disease is rare, the FDA says the risk appears to increase as patients remain on Tysabri (no shit, Sherlock!).

@ Sep 22, 2009 10:10 am - NEW YORK (AP)